Royal Cornwall Hospitals NHS Trust Breast Screening Service Goes Fully Digital

CSCCSC (NYSE: CSC) has announced that the Royal Cornwall Hospitals NHS Trust Breast Screening Service Unit has become the first unit to go-live with CSC's new breast screening solution. This pioneering deployment will make the breast screening service the first in the south west peninsula region to go fully digital.

The CSC solution has enabled the integration of technology from GE and Siemens to work with PACS (Picture Archiving Communication System), which was already in use at the trust. The investment to move from film to digital imaging for mammography is centred around the trust's Mermaid centre in Truro. The centre has three static mammographic units, with the help of two mobile mammographic units, and annually provides breast screening services to 25,000 women aged between 50 to 70.

CSC was approached by the trust to coordinate putting together a package of digital mammography for processing and storage equipment from multiple vendors in its role as the LSP (local service provider) for PACS in the region - a position it has held within the NHS National Programme for IT since the end of last year. Effectively this new CSC solution will enable full integration between its PACS solution and the NBSS (National Breast Screening System). This is part of a key deliverable set by the Department of Health (DoH) to enable all breast screening units across England to become digital by the end of 2010.

Although the screening equipment is based in Truro, the PACS suite links eleven healthcare centres in the region, offering healthcare professionals a single and more complete view of the patient throughout the initial screening, secondary screening and, if necessary, treatment stages.

The system can also display multiple forms of medical imaging data, including MRI and ultrasound scans. This saves healthcare professionals from having to load up several software suites to view individual file types separately. The solution utilises the trust's existing expenditure on PACS local storage for medical imaging files. This means that all images can be accessed locally whilst being backed-up within the CSC data centre for longer term storage.

Dr. Donna Christensen, director of the trust's breast screening service, believes the most significant breakthrough will be improved scans and better detection rates. She said: "We are very excited about the digital imaging we're now using because it is far superior to older analogue equipment. It’s going to be a fantastic improvement. In particular, it's going to be better at spotting early signs of breast cancer in dense glandular breast material. In these cases, we hope the new equipment will help us spot a third more cancers early on and offer women treatment at the earliest possible opportunity."

Alan Brimacombe, clinical imaging PACS manager for the trust, said: "I believe the 700 healthcare professionals who have access to PACS - including ward sisters, GPs, radiographers and surgeons - will not only find the digital imaging quality better but also far more convenient to work with. It's a huge leap forwards for healthcare professionals across the region to be able to share mammograms and other test images. Film would generally just sit in one place but now we can distribute a wide variety of imaging data around the region to where it is needed and, crucially, they can do this on one system with one log-on so they don't have to jump between different software packages."

Gerry O'Keeffe, CSC vice president, UK Healthcare, believes that the combination of better detection rates and the convenience of having multiple test results accessed by healthcare professionals across a region offer a strong proposition to trusts that are yet to fully embrace the opportunities of digital technology. He said: "This deployment further enhances CSC's much acclaimed PACS solution and demonstrates that we are assisting the NHS not only to improve outcomes but also to deliver benefits-driven and value-for-money solutions. All of the UK's 80 breast screening units are expected to be evaluating digital breast screening technology before the end of the year so this is a very exciting area for CSC to be offering a market-leading solution."

CSC is working on digitising breast screening services across the country and expects to be able to release further news regarding progress in several areas in the South, North West and West Midlands.

Related news articles:

  • CSC's Profile

About CSC
CSC is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions and Services, the Managed Services Sector and the North American Public Sector. CSC's advanced capabilities include system design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting. Headquartered in Falls Church, Va., CSC has approximately 95,000 employees and reported revenue of $16.2 billion for the 12 months ended July 2, 2010. For more information, visit the company's website at www.csc.com.

Although best known as the Local Service Provider delivering the NHS National Programme for IT - now covering 60% of England - CSC is about more than just IT. Because of its breadth and depth of transformational experience, CSC not only helps healthcare providers to apply its solutions intelligently, but also can help them manage the process of change. This is critical for ensuring that trusts can meet their long-term objectives - and immediate challenges - around productivity and quality enhancements, whilst meeting government targets too. For further information regarding CSC healthcare solutions in the UK visit www.csc.com/cscalliance.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...